Intercept Pharma Europe Ltd is a liquidation company incorporated on 18 September 2014 with the registered office located in . Intercept Pharma Europe Ltd was registered 11 years ago.
Termination of appointment of Quayseco Limited as a secretary on 18 March 2025
Submitted on 19 Mar 2025
Registered office address changed from One Glass Wharf Bristol BS2 0ZX to C/O Emma Cray One Chamberlain Square Birmingham West Midlands B3 3AX on 18 March 2025
Submitted on 18 Mar 2025
Resolutions
Submitted on 6 Mar 2025
Appointment of a voluntary liquidator
Submitted on 6 Mar 2025
Declaration of solvency
Submitted on 6 Mar 2025
Previous accounting period shortened from 31 December 2023 to 30 December 2023
Submitted on 13 Dec 2024
Appointment of Thomas Rosenberg as a director on 18 November 2024
Submitted on 19 Nov 2024
Confirmation statement made on 30 September 2024 with updates
Submitted on 1 Oct 2024
Termination of appointment of Kathleen Munster as a director on 24 July 2024
Submitted on 25 Jul 2024
Termination of appointment of Graham Charles Higson as a director on 27 April 2024